Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down Amid Mounting Challenges in Weight-Loss Drug Market
In a significant leadership change, Novo Nordisk announced on May 16, 2025, that CEO Lars Fruergaard Jørgensen will step down after eight years at the helm. The decision, described as mutual between Jørgensen and the board, comes as the Danish pharmaceutical giant grapples with intensified competition in the weight-loss drug sector and a notable decline […]